Rating History for Prelude Therapeutics (PRLD) by D. Boral Capital

More Stocks Rated by D. Boral Capital | Latest Ratings for PRLD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/4/2026 Jason Kolbert New Coverage Buy
(N/A)		 9.00
(N/A)		 4.70
(4.32)		 -8.09% Details